A qPCR analysis found that ESR1 and GPER1 mRNA expression was significantly reduced in the lungs of patients with end-stage IPF compared to healthy controls while there was a trend of reduced expression of ESR2 in the former group (Fig. 5a-c). The gene discussed is GPER1; the disease is idiopathic pulmonary fibrosis.